Literature DB >> 21607571

Histologic evaluation of absorbable and non-absorbable barrier coated mesh secured to the peritoneum with fibrin sealant in a New Zealand white rabbit model.

E D Jenkins1, L Melman, S Desai, C R Deeken, S C Greco, M M Frisella, B D Matthews.   

Abstract

PURPOSE: The purpose of this study is to evaluate the histologic response to fibrin sealant (FS) as an alternative fixation method for laparoscopic ventral hernia repair.
METHODS: One non-absorbable barrier mesh (Composix™) and three absorbable barrier meshes (Sepramesh™, Proceed™, and Parietex™ Composite) were used for the study, with uncoated macroporous polypropylene mesh (ProLite Ultra™) as the control. Three methods of fixation were used: #0-polypropylene suture + FS (ARTISS™, Baxter Healthcare Corp.), FS alone (ARTISS™), or tacks alone (n = 10 for each group). Two pieces of mesh (of dimensions 4 × 4-cm) were secured intraperitoneally in 75 New Zealand white rabbits. After 8 weeks, hematoxylin and eosin (H&E)-stained specimens were evaluated for host tissue response. Statistical significance (P < 0.05) was determined using a one-way analysis of variance (ANOVA) with Fisher's least significant difference (LSD) post hoc test.
RESULTS: Composix™ with FS only showed significantly greater cellular infiltration than with suture + FS (P = 0.0007), Proceed™ with FS only had significantly greater neovascularization than with suture + FS (P = 0.0172), and ProLite Ultra™ with suture + FS had significantly greater neovascularization than with tacks only (P = 0.046). Differences due to mesh type showed that Composix™ exhibited less extensive cellular infiltration (P ≤ 0.0032), extracellular matrix (ECM) deposition, and neovascularization, and demonstrated less inflammatory cells and more fibroblasts compared to the other meshes (P < 0.05).
CONCLUSIONS: FS did not have a significant histologic effect compared to tacks when utilized for the fixation of mesh to the peritoneum of New Zealand White rabbits. However, the mesh type did have a significant histologic effect. The permanent barrier mesh (Composix™) was associated with less histologic incorporation than absorbable barrier and macroporous meshes, as evidenced by lower levels of cellular infiltration, ECM deposition, and neovascularization, independent of the fixation method used.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607571      PMCID: PMC3826828          DOI: 10.1007/s10029-011-0834-9

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  16 in total

Review 1.  Laparoscopic adrenalectomy: new gold standard.

Authors:  C D Smith; C J Weber; J R Amerson
Journal:  World J Surg       Date:  1999-04       Impact factor: 3.352

2.  Evaluation of acute fixation strength of absorbable and nonabsorbable barrier coated mesh secured with fibrin sealant.

Authors:  E D Jenkins; L Melman; M M Frisella; C R Deeken; B D Matthews
Journal:  Hernia       Date:  2010-05-09       Impact factor: 4.739

3.  Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study.

Authors:  Jolene E Valentin; John S Badylak; George P McCabe; Stephen F Badylak
Journal:  J Bone Joint Surg Am       Date:  2006-12       Impact factor: 5.284

4.  Pharmaceutical approval update.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2008-05

5.  Evaluation of intraperitoneal placement of absorbable and nonabsorbable barrier coated mesh secured with fibrin sealant in a New Zealand white rabbit model.

Authors:  Eric D Jenkins; Lora Melman; Salil Desai; Shaun R Brown; Margaret M Frisella; Corey R Deeken; Brent D Matthews
Journal:  Surg Endosc       Date:  2010-07-22       Impact factor: 4.584

Review 6.  Laparoscopic splenectomy.

Authors:  N Katkhouda; E Mavor
Journal:  Surg Clin North Am       Date:  2000-08       Impact factor: 2.741

7.  Use of a mesh for musculoaponeurotic defects of the abdominal wall in cancer surgery and the risk of bowel fistulas.

Authors:  C P Karakousis; C Volpe; J Tanski; E D Colby; J Winston; D L Driscoll
Journal:  J Am Coll Surg       Date:  1995-07       Impact factor: 6.113

8.  Laparoscopic cholecystectomy. The new 'gold standard'?

Authors:  N J Soper; P T Stockmann; D L Dunnegan; S W Ashley
Journal:  Arch Surg       Date:  1992-08

9.  Local injection for the treatment of suture site pain after laparoscopic ventral hernia repair.

Authors:  Alfredo M Carbonell; Kristi L Harold; Aida J Mahmutovic; Reem Hassan; Brent D Matthews; Kent W Kercher; Ronald F Sing; B Todd Heniford
Journal:  Am Surg       Date:  2003-08       Impact factor: 0.688

Review 10.  Pooled data analysis of laparoscopic vs. open ventral hernia repair: 14 years of patient data accrual.

Authors:  Richard A Pierce; Jennifer A Spitler; Margaret M Frisella; Brent D Matthews; L Michael Brunt
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 3.453

View more
  3 in total

1.  Fibrin sealant for mesh fixation in laparoscopic umbilical hernia repair: 1-year results of a randomized controlled double-blinded study.

Authors:  J R Eriksen; T Bisgaard; S Assaadzadeh; L N Jorgensen; J Rosenberg
Journal:  Hernia       Date:  2013-05-09       Impact factor: 4.739

2.  Remodeling characteristics and collagen distribution in synthetic mesh materials explanted from human subjects after abdominal wall reconstruction: an analysis of remodeling characteristics by patient risk factors and surgical site classifications.

Authors:  Jaime A Cavallo; Andres A Roma; Mateusz S Jasielec; Jenny Ousley; Jennifer Creamer; Matthew D Pichert; Sara Baalman; Margaret M Frisella; Brent D Matthews; Corey R Deeken
Journal:  Surg Endosc       Date:  2014-01-18       Impact factor: 4.584

3.  Critical analysis of experimental model for study of adhesions after incisional hernias induced in rats' and repair of abdominal wall with different biomaterials.

Authors:  Leonardo Carvalho Serigiolle; Renato Lamounier Barbieri; Helbert Minuncio Pereira Gomes; Daren Athiê Boy Rodrigues; Sarah do Valle Studart; Pedro Luiz Squilacci Leme
Journal:  Arq Bras Cir Dig       Date:  2015 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.